NASDAQ:BPMC
$47.78
(
0.0628%
)
Friday, 27th Jan 2023
Blueprint Medicines Corporation Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $41.72 | $51.07 | Friday, 27th Jan 2023 BPMC stock ended at $47.78. This is 0.0628% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 2.12% from a day low at $47.01 to a day high of $48.00. |
| 90 days | $40.78 | $53.81 | |
| 52 weeks | $40.78 | $85.67 |
Historical Blueprint Medicines Corporation prices
| Date | Open | High | Low | Close | Volume |
| 2023-01-27 | $47.23 | $48.00 | $47.01 | $47.78 | 282 590 |
| 2023-01-26 | $47.04 | $47.83 | $46.09 | $47.75 | 369 763 |
| 2023-01-25 | $47.68 | $47.94 | $46.02 | $46.65 | 305 120 |
| 2023-01-24 | $46.51 | $47.99 | $45.73 | $47.97 | 413 570 |
| 2023-01-23 | $46.58 | $47.18 | $45.11 | $46.51 | 583 834 |
| 2023-01-20 | $47.07 | $47.35 | $45.96 | $46.69 | 421 800 |
| 2023-01-19 | $46.56 | $47.67 | $45.03 | $46.40 | 437 200 |
| 2023-01-18 | $47.63 | $48.72 | $46.54 | $46.65 | 633 900 |
| 2023-01-17 | $47.58 | $48.19 | $46.54 | $47.37 | 463 134 |
| 2023-01-13 | $49.45 | $51.07 | $46.60 | $47.85 | 717 900 |
| 2023-01-12 | $46.82 | $50.41 | $46.45 | $50.00 | 502 200 |
| 2023-01-11 | $47.09 | $47.96 | $46.30 | $46.82 | 616 916 |
| 2023-01-10 | $45.80 | $47.25 | $45.73 | $47.19 | 340 200 |
| 2023-01-09 | $47.26 | $47.42 | $45.75 | $45.78 | 371 344 |
| 2023-01-06 | $46.41 | $47.65 | $44.81 | $46.87 | 304 100 |
| 2023-01-05 | $47.70 | $48.00 | $46.14 | $47.01 | 561 285 |
| 2023-01-04 | $43.69 | $47.44 | $43.69 | $47.37 | 483 460 |
| 2023-01-03 | $45.46 | $45.47 | $42.87 | $43.30 | 478 804 |
| 2022-12-30 | $42.38 | $43.87 | $41.95 | $43.81 | 441 430 |
| 2022-12-29 | $42.50 | $43.97 | $41.97 | $43.00 | 529 992 |
| 2022-12-28 | $41.85 | $42.92 | $41.72 | $42.18 | 362 467 |
| 2022-12-27 | $43.98 | $43.99 | $41.87 | $41.92 | 299 031 |
| 2022-12-23 | $44.46 | $44.69 | $43.10 | $44.15 | 452 617 |
| 2022-12-22 | $43.85 | $44.93 | $43.18 | $44.60 | 453 461 |
| 2022-12-21 | $44.17 | $45.48 | $43.85 | $44.54 | 516 702 |
| 2022-12-20 | $42.61 | $44.57 | $42.61 | $43.79 | 474 111 |
| 2022-12-19 | $44.72 | $45.47 | $42.33 | $42.97 | 589 878 |
| 2022-12-16 | $44.66 | $45.77 | $43.39 | $45.22 | 1 616 260 |
| 2022-12-15 | $45.99 | $46.53 | $44.53 | $45.11 | 478 963 |
| 2022-12-14 | $47.48 | $48.20 | $46.30 | $46.73 | 444 622 |
| 2022-12-13 | $46.67 | $47.41 | $45.18 | $46.60 | 470 487 |
| 2022-12-12 | $47.31 | $47.31 | $45.02 | $45.42 | 659 939 |
| 2022-12-09 | $46.59 | $47.51 | $46.38 | $47.24 | 427 708 |
| 2022-12-08 | $46.84 | $47.11 | $45.32 | $46.78 | 568 667 |
| 2022-12-07 | $48.11 | $48.58 | $46.68 | $46.85 | 371 965 |
| 2022-12-06 | $49.97 | $50.11 | $48.00 | $48.51 | 510 685 |
| 2022-12-05 | $48.55 | $50.53 | $47.50 | $50.19 | 821 614 |
| 2022-12-02 | $46.90 | $49.04 | $46.65 | $48.93 | 651 513 |
| 2022-12-01 | $47.79 | $48.45 | $47.30 | $47.49 | 599 079 |
| 2022-11-30 | $46.93 | $47.93 | $45.58 | $47.79 | 614 313 |
| 2022-11-29 | $45.38 | $46.94 | $45.38 | $46.60 | 922 314 |
| 2022-11-28 | $44.78 | $45.81 | $44.41 | $45.23 | 614 656 |
| 2022-11-25 | $44.32 | $45.17 | $44.15 | $44.89 | 173 508 |
| 2022-11-23 | $43.67 | $46.15 | $43.67 | $44.83 | 697 168 |
| 2022-11-22 | $43.24 | $44.07 | $42.31 | $43.57 | 551 893 |
| 2022-11-21 | $42.10 | $43.19 | $41.73 | $42.99 | 448 531 |
| 2022-11-18 | $43.34 | $43.35 | $41.93 | $42.53 | 227 756 |
| 2022-11-17 | $42.04 | $42.71 | $41.06 | $42.17 | 213 524 |
| 2022-11-16 | $43.46 | $43.71 | $42.37 | $42.49 | 319 368 |
| 2022-11-15 | $43.06 | $43.89 | $42.86 | $43.52 | 249 134 |
About Blueprint Medicines Corporation
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally avail... BPMC Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
